SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Unicycive Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update

MOUNTAIN VIEW, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) NASDAQ:UNCY, a biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the third quarter ended September 30, 2026, and…

UNCY

Related stories